Skip to content
+34 93 202 34 56
Linkedin page opens in new window
  • Español
  • English
Grau & Angulo Abogados
Grau & Angulo Abogados
Grau & Angulo Abogados
  • Services
    • Advice
    • Litigation
    • Anti-piracy
  • Team
  • News
    • Newsletter
    • News G&A
  • Careers
  • Contact Us
  • Services
    • Advice
    • Litigation
    • Anti-piracy
  • Team
  • News
    • Newsletter
    • News G&A
  • Careers
  • Contact Us

Daily Archives: June 22, 2018

Barcelona patent court upholds valsartan-amlodipine patent invalidity

NewsBy Grau & Angulo AbogadosJune 22, 2018

On 14 March 2018 the Barcelona Commercial Court Number 4 dismissed a patent infringement action brought by Novartis against the first generics in Spain of its valsartan and amlodipine medicinal product for the treatment of hypertension (Exforge). The court upheld the defendants’ counterclaim for invalidity of the asserted patent.

Grau & Angulo Abogados

Privacy Policy and Conditions for Use | © Grau & Angulo Lawyers 2016

Go to Top

[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin